CBTN Launches New Brand to Highlight Research Advancements
The Children's Brain Tumor Network (CBTN), a pivotal figure in pediatric brain tumor research, has announced an exciting evolution in its branding. This change is designed to enhance the way the organization conveys its mission and achievements in tackling the challenges of pediatric brain tumors.
A Vision of Unification in Research
Established in 2011, CBTN has been instrumental in bringing together an array of players in the field—research institutions, clinicians, families, and various foundations—all united under a groundbreaking model of open science and real-time collaboration. The new branding signifies the growth of this collaborative ecosystem, underscoring CBTN's role as a leader in the domain of data-driven research aimed at children suffering from brain tumors.
A Statement from Leadership
Adam Resnick, PhD, Co-Executive Director at the Center for Data-Driven Discovery in Biomedicine (D3b), voiced the organization's commitment to scientific exploration: "CBTN has matured into a global, cloud-enabled research engine. This is the right moment to capture the sophistication of the ecosystem we've built and the advancements it enables." This update effectively highlights the broad and impactful engagement of CBTN within the research community.
Strategic Enhancements in Communication
The updated brand features a vibrant visual identity, contemporary messaging, and a fortified digital presence, all aimed at better facilitating access to the wealth of data and resources CBTN offers. This overhaul is intended to promote greater engagement from international partners and maintain consistent communication across the board.
Commitment to Clarity and Connection
Wendy Payton, Director of Communications at CBTN, emphasized the importance of clarity in the network's communication. She stated, "This update allows us to illustrate the strength of our collaborative efforts more clearly, making it easier for partners to join in our mission." This focus on precise communication informs how CBTN articulates its goals and accomplishments within the scientific community.
United We Cure: The Heart of CBTN's Message
At the core of CBTN's refreshed messaging is the inspiring mantra "United We Cure." This phrase encapsulates the network's commitment to collaboration in the pursuit of scientific breakthroughs. The essence of this communication encourages individuals and institutions alike to join in the fight against pediatric brain tumors, bringing together a community dedicated to improving treatments and outcomes for affected children.
About the Children's Brain Tumor Network
CBTN is recognized as a global leader in accelerating research discoveries for children and young adults battling brain tumors. The organization offers harmonized clinical data, genomic resources, biospecimens, imaging studies, and preclinical models through cloud-enabled platforms, facilitating real-time cooperation among diverse research institutions and disciplines.
Engagement and Participation
By enhancing its branding and communications strategy, CBTN aims to not only amplify its visibility but also to broaden its network of collaborators. This initiative is designed to attract new partnerships, further enriching the resources available for research and the ongoing battle against pediatric brain tumors.
Frequently Asked Questions
What is the main purpose of CBTN's updated branding?
The updated branding aims to enhance communication about CBTN's mission and impact in pediatric brain tumor research.
How does CBTN support research initiatives?
CBTN provides clinical and genomic data, along with other essential resources to enable real-time collaboration among researchers.
What is the significance of the motto 'United We Cure'?
This motto reflects CBTN's commitment to collaborative efforts in advancing treatments for children facing brain tumors.
Who can engage with CBTN's network?
Researchers, clinicians, families, and institutions are all invited to participate in the CBTN network.
How long has CBTN been operating?
CBTN has been advancing pediatric brain tumor research since its establishment in 2011.
